Results 61 to 70 of about 10,600 (216)

The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease

Journal of Internal Medicine, Volume 299, Issue 3, Page 328-348, March 2026.
Abstract The etiology of Alzheimer's disease (AD) remains under active debate. In this perspective, we explore the hypothesis that a primarily infection‐caused chronic dysregulation and weakening of human innate immunity via the underexpression, degradation, and inactivation of innate immune proteins necessary for direct antimicrobial effects and ...
Annelise E. Barron, Jennifer S. Lin, Mark I. Ryder, Peter Bergman   +3 more
wiley   +1 more source

Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine

Vaccines
Background: Currently, the recombinant subunit vaccine and live attenuated vaccine in the prevention of herpes zoster are approved for marketing in China.
Jiaqi Wang, Pengfei Jin, Hui Jin, Qiang Wang, Fengcai Zhu, Jingxin Li   +5 more
doaj   +1 more source

Murine cytomegalovirus genomic material in marrow cells; relation to altered leukocyte counts during sublethal infection of mice [PDF]

, 1987
To investigate infection of hematopoietic cells by murine cytomegalovirus (MCMV), we used in situ hybridization to detect MCMV genomic material in marrow cells during sublethal infection of three-week-old mice.
Bale, J. F., Giller, R., Koszinowski, Ulrich H., O'Neil, M. E., Perlman, S.   +4 more
core   +1 more source

Herpes Zoster following Recombinant COVID-19 Vaccine: A Case Series

Clinical Dermatology Review, 2023
The ongoing novel coronavirus pandemic caused by the SARS-COV-2 virus has severely affected the global population. As various vaccines are being introduced to combat this virus, several adverse effects are being commonly reported such as mucocutaneous reactions, local injection site reactions, and delayed hypersensitivity reactions manifesting as ...
Shreya Poddar, Indrashis Podder
openaire   +2 more sources

Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors

International Journal of Dermatology, Volume 65, Issue 2, Page 230-237, February 2026.
Inmunization and Screening Protocol for the Safe Initiation of JAK Inhibitors. ABSTRACT Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine ...
Mariano Ara‐Martín, Carolina Moreno, Ricardo Ruiz‐Villaverde, Esther Serra‐Baldrich, Irene Hernández‐Martín, Maria del Pilar Fortes   +5 more
wiley   +1 more source

Bibliometric analysis and visualization mapping of herpes zoster vaccine publications from 1999 to 2024

Frontiers in Medicine
BackgroundHerpes Zoster (HZ) is a viral skin disease caused by reactivation of latent Varicella Zoster Virus (VZV) in human ganglia, presenting with unilateral neuropathic pain and vesicular rash.
Wenli Gao, Dongyang Gao, Lin Li, Juan Li, Xinyi Yao, Junling Zhang   +5 more
doaj   +1 more source

Herpes zoster infection in patients with inflammatory bowel disease [PDF]

The Korean Journal of Internal Medicine
Patients with inflammatory bowel disease (IBD) are at increased risk of herpes zoster (HZ), particularly those receiving immunosuppressive treatments such as corticosteroids, thiopurines, and biologics, which elevate the likelihood of varicella-zoster ...
Dong Hyun Kim, Sang-Bum Kang
doaj   +1 more source

Review of Varicella zoster virus : from epidemiology to prevention [PDF]

, 2008
The Varicella zoster virus is a human pathogen which causes Varicella after primary infection and herpes zoster after secondary reactivation. Both disease manifestations can occur at any age; however, Varicella is seen more commonly in children whilst ...
Pace, David
core  

SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults

European Journal of Immunology, Volume 56, Issue 1, January 2026.
SARS‐CoV‐2 mRNA vaccination triggers bystander activation of B cells, transiently increasing antibody levels after the first vaccination against influenza, RSV, and tetanus. Reactivation of B cell responses also occurred, where (CD11c+) MBC and DN3 are expanded after SARS‐CoV‐2 mRNA vaccination, independent of antigen exposure.
Lisan H. Kuijper, Laura Y. L. Kummer, Laura Fernandez Blanco, Karlijn van der Straten, Mathieu A. F. Claireaux, Amélie V. Bos, Miranda C. Dieker‐Meijer, Tineke Jorritsma, Mariël C. Duurland, Maurice Steenhuis, Juan J. Garcia Vallejo, Koos P. J. van Dam, Eileen W. Stalman, Luuk Wieske, Sander W. Tas, Laura Boekel, Gert‐Jan Wolbink, Theo Rispens, Taco W. Kuijpers, Filip Eftimov, Marit J. van Gils, Anja ten Brinke, S. Marieke van Ham, T2B! immunity against SARS‐CoV‐2 study group   +23 more
wiley   +1 more source

Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms [PDF]

, 2016
The continued success of the live attenuated varicella-zoster virus vaccine in preventing varicella-zoster and herpes zoster is well documented, as are many of the mutations that contribute to the attenuation of the vOka virus for replication in skin. At
Breuer, J, Depledge, DP, Gershon, AA, Gomi, Y, Yamanishi, K   +4 more
core   +1 more source